Healthcare -
Biotechnology - NASDAQ - US
$ 0.7556
-7.85 %
$ 4.11 M
Market Cap
-0.01
P/E
ALZN - TOTAL EQUITY
Total Equity ALZN - Alzamend Neuro, Inc.
-2.59 M
LAST VALUE
-9.28%
2 YEAR CAGR
-55.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR